Align Technology | ALGN - Umlaufvermögen

Aktienkurs
177.33
Täglich Wechseln
-2.94 -1.63%
Monatlich
-6.72%
Jährlich
7.94%
Q1 Prognose
174.94




Umlaufvermögen Veränderung Datum
3M USD 16.39B 298M 2025-12
Align Technology USD 2.62B 82.47M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Bruker USD 2.21B 138.1M 2025-12
Cardinal Health USD 39.23B 693M 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Cooper Companies USD 2.13B 27.4M 2025-12
CVS Health USD 74.71B 2.4B 2025-12
Danaher USD 12.76B 3.15B 2025-12
Dentsply International USD 2.02B 49M 2025-12
Dexcom USD 4.03B 1.19B 2025-12
Henry Schein USD 4.46B 69M 2025-12
Idexx Laboratories USD 1.41B 63.23M 2025-12
Insulet USD 1.91B 54.6M 2025-12
Integra LifeSciences USD 1.16B 15.96M 2025-12
IQVIA Holdings USD 6.25B 270M 2025-12
Masimo USD 926M 122.3M 2025-12
McKesson USD 59.7B 190M 2025-12
Mettler Toledo International USD 1.36B 81.46M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Solventum Corp USD 3.86B 548M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Teleflex USD 1.94B 47.65M 2025-12
Thermo Fisher Scientific USD 28.71B 6.41B 2025-12
Veeva Systems USD 8B 885.78M 2025-12
Waters USD 1.99B 69.86M 2025-12
Zimmer Biomet Holdings USD 5.12B 715M 2025-12
Zoetis USD 6.77B 185M 2025-12